Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Bauermeister, G
   Endovascular stent-grafting in the treatment of superficial femoral arteryocclusive disease
   JOURNAL OF ENDOVASCULAR THERAPY
   
   G. Bauermeister, "Endovascular stent-grafting in the treatment of superficial femoral arteryocclusive disease", J ENDOVAS T, 8(3), 2001, pp. 315-320
2. Scheinert, D; Laird, JR; Schroder, M; Steinkamp, H; Balzer, JO; Biamino, G
   Excimer laser-assisted recanalization of long, chronic superficial femoralartery occlusions
   JOURNAL OF ENDOVASCULAR THERAPY
   
   D. Scheinert et al., "Excimer laser-assisted recanalization of long, chronic superficial femoralartery occlusions", J ENDOVAS T, 8(2), 2001, pp. 156-166
3. Van de Werf, F
   New aspects of pharmacological reperfusion: from macro- to microlysis
   EUROPEAN HEART JOURNAL SUPPLEMENTS
   
   F. Van de Werf, "New aspects of pharmacological reperfusion: from macro- to microlysis", EUR H J SUP, 3(C), 2001, pp. C62-C68
4. Gershlick, AH
   Keeping the coronary arteries open: current opportunities
   HOSPITAL MEDICINE
   
   A.H. Gershlick, "Keeping the coronary arteries open: current opportunities", HOSP MED, 62(10), 2001, pp. 617-622
5. Guerrero, B; Arocha-Pinango, CL; Pinto, MA; Muller, CA; San Juan, AG; Amorim, S; Perales, J
   Thrombolytic effect of lonomin V in a rabbit jugular vein thrombosis model
   BLOOD COAGULATION & FIBRINOLYSIS
   
   B. Guerrero et al., "Thrombolytic effect of lonomin V in a rabbit jugular vein thrombosis model", BL COAG FIB, 12(7), 2001, pp. 521-529
6. Gyongyosi, M; Wexberg, P; Kiss, K; Yang, P; Sperker, W; Sochor, H; Laggner, A; Glogar, D
   Adaptive remodeling of the infarct-related artery is associated with recurrent ischemic events after thrombolysis in acute myocardial infarction
   CORONARY ARTERY DISEASE
   
   M. Gyongyosi et al., "Adaptive remodeling of the infarct-related artery is associated with recurrent ischemic events after thrombolysis in acute myocardial infarction", CORON ART D, 12(3), 2001, pp. 167-172
7. Scrutinio, D; Cimminiello, C; Marubini, E; Pitzalis, MV; Di Biase, M; Rizzon, P
   Ticlopidine versus aspirin after myocardial infarction (STAMI) trial
   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
   
   D. Scrutinio et al., "Ticlopidine versus aspirin after myocardial infarction (STAMI) trial", J AM COL C, 37(5), 2001, pp. 1259-1265
8. Grotta, JC; Welch, KMA; Fagan, SC; Lu, M; Frankel, MR; Brott, T; Levine, SR; Lyden, PD
   Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial
   STROKE
   
   J.C. Grotta et al., "Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial", STROKE, 32(3), 2001, pp. 661-668
9. Kitamura, S; Fukushi, H; Miyawaki, T; Kawamura, M; Konishi, N; Terashita, Z; Naka, T
   Potent dibasic GPIIb/IIIa antagonists with reduced prolongation of bleeding time: Synthesis and pharmacological evaluation of 2-oxopiperazine derivatives
   JOURNAL OF MEDICINAL CHEMISTRY
   
   S. Kitamura et al., "Potent dibasic GPIIb/IIIa antagonists with reduced prolongation of bleeding time: Synthesis and pharmacological evaluation of 2-oxopiperazine derivatives", J MED CHEM, 44(15), 2001, pp. 2438-2450
10. Barbash, GI; Birnbaum, Y; Bogaerts, K; Hudson, M; Lesaffre, E; Fu, YL; Goodman, S; Houbracken, K; Munsters, K; Granger, CB; Pieper, K; Califf, RM; Topol, EJ; Van de Werf, F
    Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction - An analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO I) and assessment of the safety of a new thrombolytic(ASSENT 2) studies
    CIRCULATION
    
    G.I. Barbash et al., "Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction - An analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO I) and assessment of the safety of a new thrombolytic(ASSENT 2) studies", CIRCULATION, 103(7), 2001, pp. 954-960
11. Gershlick, AH
    Antiplatelet therapy
    HOSPITAL MEDICINE
    
    A.H. Gershlick, "Antiplatelet therapy", HOSP MED, 61(1), 2000, pp. 15-23
12. Watson, HR; Bergqvist, D
    Antithrombotic agents after peripheral transluminal angioplasty: a review of the studies, methods and evidence for their use
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
    
    H.R. Watson e D. Bergqvist, "Antithrombotic agents after peripheral transluminal angioplasty: a review of the studies, methods and evidence for their use", EUR J VAS E, 19(5), 2000, pp. 445-450
13. Serebruany, VL; Lowry, DR; Fuzailov, SY; Levine, DJ; O'Connor, CM; Gurbel, PA
    Moderate alcohol consumption is associated with decreased platelet activity in patients presenting with acute myocardial infarction
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    
    V.L. Serebruany et al., "Moderate alcohol consumption is associated with decreased platelet activity in patients presenting with acute myocardial infarction", J THROMB TH, 9(3), 2000, pp. 229-234
14. Vermeer, F; Vahanian, A; Fels, PW; Besse, P; Muller, E; Van de Werf, F; Fitzgerald, D; Darius, H; Puel, J; Garrigou, D; Simoons, ML
    Argatroban and alteplase in patients with acute myocardial infarction: TheARGAMI study
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    
    F. Vermeer et al., "Argatroban and alteplase in patients with acute myocardial infarction: TheARGAMI study", J THROMB TH, 10(3), 2000, pp. 233-240
15. Waksman, R; Bhargava, B; Mintz, GS; Mehran, R; Lansky, AJ; Satler, LF; Pichard, AD; Kent, KM; Leon, MB
    Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    R. Waksman et al., "Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis", J AM COL C, 36(1), 2000, pp. 65-68
16. Qasim, A; Chauhan, A; More, RS
    Failed thrombolysis in myocardial infarction
    INTERNATIONAL JOURNAL OF CARDIOLOGY
    
    A. Qasim et al., "Failed thrombolysis in myocardial infarction", INT J CARD, 75(1), 2000, pp. 5-14
17. Yoshino, H; Kachi, E; Shimizu, H; Taniuchi, M; Yano, K; Udagawa, H; Kajiwara, T; Shimoyama, K; Ishikawa, K
    Severity of residual stenosis of infarct-related lesion and left ventricular function after single-vessel anterior wall myocardial infarction: Implication of ST-segment elevation in lead aVL of the admission electrocardiograms
    CLINICAL CARDIOLOGY
    
    H. Yoshino et al., "Severity of residual stenosis of infarct-related lesion and left ventricular function after single-vessel anterior wall myocardial infarction: Implication of ST-segment elevation in lead aVL of the admission electrocardiograms", CLIN CARD, 23(3), 2000, pp. 175-180
18. Li, M; Goto, S; Sakai, H; Kim, JY; Ichikawa, N; Yoshida, M; Ikeda, Y; Handa, S
    Enhanced shear-induced von Willebrand factor binding to platelets in acutemyocardial infarction
    THROMBOSIS RESEARCH
    
    M. Li et al., "Enhanced shear-induced von Willebrand factor binding to platelets in acutemyocardial infarction", THROMB RES, 100(4), 2000, pp. 251-261
19. Pakala, R; Liang, CT; Benedict, CR
    Inhibition of arterial thrombosis by a peptide ligand of the thrombin receptor
    THROMBOSIS RESEARCH
    
    R. Pakala et al., "Inhibition of arterial thrombosis by a peptide ligand of the thrombin receptor", THROMB RES, 100(1), 2000, pp. 89-96
20. Jackson, CV; Bailey, BD; Shetler, TJ
    Pharmacological profile of recombinant, human activated protein C (LY203638) in a canine model of coronary artery thrombosis
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    C.V. Jackson et al., "Pharmacological profile of recombinant, human activated protein C (LY203638) in a canine model of coronary artery thrombosis", J PHARM EXP, 295(3), 2000, pp. 967-971
21. Peter, K; Kohler, B; Straub, A; Ruef, J; Moser, M; Nordt, T; Olschewski, M; Ohman, ME; Kubler, W; Bode, C
    Flow cytometric monitoring of glycoprotein IIb/IIIa blockade and platelet function in patients with acute myocardial infarction receiving reteplase, abciximab, and ticlopidine - Continuous platelet inhibition by the combination of abciximab and ticlopidine
    CIRCULATION
    
    K. Peter et al., "Flow cytometric monitoring of glycoprotein IIb/IIIa blockade and platelet function in patients with acute myocardial infarction receiving reteplase, abciximab, and ticlopidine - Continuous platelet inhibition by the combination of abciximab and ticlopidine", CIRCULATION, 102(13), 2000, pp. 1490-1496
22. Ragni, M; Golina, P; Cirillo, P; Scognamiglio, A; Piro, O; Esposito, N; Battaglia, C; Botticella, F; Ponticelli, P; Ramunno, L; Chiariello, M
    Endogenous tissue factor pathway inhibitor modulates thrombus formation inan in vivo model of rabbit carotid artery stenosis and endothelial injury
    CIRCULATION
    
    M. Ragni et al., "Endogenous tissue factor pathway inhibitor modulates thrombus formation inan in vivo model of rabbit carotid artery stenosis and endothelial injury", CIRCULATION, 102(1), 2000, pp. 113-117
23. Zoldhelyi, P; McNatt, J; Shelat, HS; Yamamoto, Y; Chen, ZQ; Willerson, JT
    Thromboresistance of balloon-injured porcine carotid arteries after local gene transfer of human tissue factor pathway inhibitor
    CIRCULATION
    
    P. Zoldhelyi et al., "Thromboresistance of balloon-injured porcine carotid arteries after local gene transfer of human tissue factor pathway inhibitor", CIRCULATION, 101(3), 2000, pp. 289-295
24. Armstrong, PW; Burton, JR; Palisaitis, D; Thompson, CR; Van de Werf, F; Rose, B; Collen, D; Teo, KK
    Collaborative Angiographic Patency Trial of Recombinant Staphylokinase (CAPTORS)
    AMERICAN HEART JOURNAL
    
    P.W. Armstrong et al., "Collaborative Angiographic Patency Trial of Recombinant Staphylokinase (CAPTORS)", AM HEART J, 139(5), 2000, pp. 820-823
25. Theroux, P
    Antiplatelet drugs in the acute phase of myocardial infarction
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    P. Theroux, "Antiplatelet drugs in the acute phase of myocardial infarction", EUR H J SUP, 1(F), 1999, pp. F29-F33
26. Astorri, E; Garini, A; Pedroni, G; Ferrari, O; Bonifazi, C
    Prediction of infarct-related coronary artery patency after thrombolytic therapy in acute myocardial infarction: Use of ST-segment as a non-invasive marker
    Journal of cardiovascular diagnosis and procedures
    
    E. Astorri et al., "Prediction of infarct-related coronary artery patency after thrombolytic therapy in acute myocardial infarction: Use of ST-segment as a non-invasive marker", J CARDIO D, 16(2), 1999, pp. 99-106
27. Cohen, M
    Treatment of unstable angina: The role of platelet inhibitors and anticoagulants
    JOURNAL OF INVASIVE CARDIOLOGY
    
    M. Cohen, "Treatment of unstable angina: The role of platelet inhibitors and anticoagulants", J INVAS CAR, 11(3), 1999, pp. 147-159
28. Menown, IBA; Adgey, AAJ
    Improving reperfusion after myocardial infarction - Using glycoprotein IIb/IIIb antagonists as adjuncts to fibrinolytic therapy holds promise
    BRITISH MEDICAL JOURNAL
    
    I.B.A. Menown e A.A.J. Adgey, "Improving reperfusion after myocardial infarction - Using glycoprotein IIb/IIIb antagonists as adjuncts to fibrinolytic therapy holds promise", BR MED J, 319(7224), 1999, pp. 1513-1515
29. Holper, EM; Giugliano, RP; Antman, EM
    Glycoprotein IIb/IIIa inhibitors in acute ST segment elevation myocardial infarction
    CORONARY ARTERY DISEASE
    
    E.M. Holper et al., "Glycoprotein IIb/IIIa inhibitors in acute ST segment elevation myocardial infarction", CORON ART D, 10(8), 1999, pp. 567-573
30. Fox, KAA
    Have we reached the limit with thrombolytic therapy?
    CARDIOVASCULAR DRUGS AND THERAPY
    
    K.A.A. Fox, "Have we reached the limit with thrombolytic therapy?", CARDIO DRUG, 13(3), 1999, pp. 211-216
31. Cannon, CP
    Overcoming thrombolytic resistance - Rationale and initial clinical experience combining thrombolytic therapy and glycoprotein IIb/IIIa receptor inhibition for acute myocardial infarction
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    C.P. Cannon, "Overcoming thrombolytic resistance - Rationale and initial clinical experience combining thrombolytic therapy and glycoprotein IIb/IIIa receptor inhibition for acute myocardial infarction", J AM COL C, 34(5), 1999, pp. 1395-1402
32. Neuhaus, KL; Molhoek, GP; Zeymer, U; Tebbe, U; Wegscheider, K; Schroder, R; Camez, A; Laarman, GJ; Grollier, GR; Lok, DJA; Kuckuck, H; Lazarus, P
    Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction - Results of the HIT-4 trial
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    K.L. Neuhaus et al., "Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction - Results of the HIT-4 trial", J AM COL C, 34(4), 1999, pp. 966-973
33. Aviles, FF
    Editorial comment. Infarct-related artery after thrombolysis: to see or not to see?
    REVISTA ESPANOLA DE CARDIOLOGIA
    
    F.F. Aviles, "Editorial comment. Infarct-related artery after thrombolysis: to see or not to see?", REV ESP CAR, 52(2), 1999, pp. 103-104
34. Aviles, FF; Galan, LDF; Duran, JM; Gimeno, F; Ramos, B; Alonso, JJ; Garcimartin, I
    Acute coronary syndromes, role of angioplasty in the stent-era
    REVISTA ESPANOLA DE CARDIOLOGIA
    
    F.F. Aviles et al., "Acute coronary syndromes, role of angioplasty in the stent-era", REV ESP CAR, 52, 1999, pp. 131-140
35. Williams, MJA; Stewart, RAH
    Coronary artery flow ten weeks after myocardial infarction or unstable angina: effects of combined warfarin and aspirin therapy
    INTERNATIONAL JOURNAL OF CARDIOLOGY
    
    M.J.A. Williams e R.A.H. Stewart, "Coronary artery flow ten weeks after myocardial infarction or unstable angina: effects of combined warfarin and aspirin therapy", INT J CARD, 69(1), 1999, pp. 19-25
36. Branzi, A; Melandri, G; Semprini, F; Descovich, B; Nanni, S; Cervi, V
    Long-term arterial patency after coronary reperfusion
    INTERNATIONAL JOURNAL OF CARDIOLOGY
    
    A. Branzi et al., "Long-term arterial patency after coronary reperfusion", INT J CARD, 68, 1999, pp. S29-S33
37. Takazoe, K; Ogawa, H; Yasue, H; Sakamoto, T; Oshima, S; Arai, H; Moriyama, Y; Shimomura, H; Hirai, N; Kaikita, K; Soejima, H; Misumi, K; Hosoda, K
    Association of plasma levels of activated protein C with recanalization ofthe infarct-related coronary artery after thrombolytic therapy in acute myocardial infarction
    THROMBOSIS RESEARCH
    
    K. Takazoe et al., "Association of plasma levels of activated protein C with recanalization ofthe infarct-related coronary artery after thrombolytic therapy in acute myocardial infarction", THROMB RES, 95(1), 1999, pp. 37-47
38. Oshima, S; Saito, T; Nakamura, S; Noda, K; Date, H; Hokimoto, S; Taniguchi, I; Yamamoto, N
    Percutaneous transluminal coronary angioplasty, alone or in combination with urokinase therapy, during acute myocardial infarction
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION
    
    S. Oshima et al., "Percutaneous transluminal coronary angioplasty, alone or in combination with urokinase therapy, during acute myocardial infarction", JPN CIRC J, 63(2), 1999, pp. 91-96
39. Grines, CL; Cox, DA; Stone, GW; Garcia, E; Mattos, LA; Giambartolomei, A; Brodie, BR; Madonna, O; Eijgelshoven, M; Lansky, AJ; O'Neill, WW; Morice, MC
    Coronary angioplasty with or without stent implantation for acute myocardial infarction
    NEW ENGLAND JOURNAL OF MEDICINE
    
    C.L. Grines et al., "Coronary angioplasty with or without stent implantation for acute myocardial infarction", N ENG J MED, 341(26), 1999, pp. 1949-1956
40. Hansen, PS; Rasmussen, HH; Vinen, J; Nelson, GIC
    A primary stenting strategy as an alternative to fibrinolytic therapy in acute myocardial infarction - An analysis of results in hospital and at 6 weeks and 6 months
    MEDICAL JOURNAL OF AUSTRALIA
    
    P.S. Hansen et al., "A primary stenting strategy as an alternative to fibrinolytic therapy in acute myocardial infarction - An analysis of results in hospital and at 6 weeks and 6 months", MED J AUST, 170(11), 1999, pp. 537-540
41. Steinmetzer, T; Zhu, BY; Konishi, Y
    Potent bivalent thrombin inhibitors: Replacement of the scissile peptide bond at P-1-P-1 ' with arginyl ketomethylene isosteres
    JOURNAL OF MEDICINAL CHEMISTRY
    
    T. Steinmetzer et al., "Potent bivalent thrombin inhibitors: Replacement of the scissile peptide bond at P-1-P-1 ' with arginyl ketomethylene isosteres", J MED CHEM, 42(16), 1999, pp. 3109-3115
42. Antman, EM; Giugliano, RP; Gibson, CM; McCabe, CH; Coussement, P; Kleiman, NS; Vahanian, A; Adgey, AAJ; Menown, I; Rupprecht, HJ; Van der Wieken, R; Ducas, J; Scherer, J; Anderson, K; Van de Werf, F; Braunwald, E
    Abciximab facilitates the rate and extent of thrombolysis - Results of thethrombolysis in myocardial infarction (TIMI) 14 trial
    CIRCULATION
    
    E.M. Antman et al., "Abciximab facilitates the rate and extent of thrombolysis - Results of thethrombolysis in myocardial infarction (TIMI) 14 trial", CIRCULATION, 99(21), 1999, pp. 2720-2732
43. Veen, G; de Boer, MJ; Zijlstra, F; Verheugt, FWA
    Improvement in three-month angiographic outcome suggested after primary angioplasty for acute myocardial infarction (Zwolle trial) compared with successful thrombolysis (APRICOT trial)
    AMERICAN JOURNAL OF CARDIOLOGY
    
    G. Veen et al., "Improvement in three-month angiographic outcome suggested after primary angioplasty for acute myocardial infarction (Zwolle trial) compared with successful thrombolysis (APRICOT trial)", AM J CARD, 84(7), 1999, pp. 763-767
44. URIUDA Y; WANG QD; HATORI N; NORDLANDER R; SJOQUIST PO; MATTSSON C; RYDEN L
    CORONARY THROMBOSIS THROMBOLYSIS IN PIGS - EFFECTS OF HEPARIN, ASA, AND THE THROMBIN INHIBITOR INOGATRAN/
    Journal of pharmacological and toxicological methods
    
    Y. Uriuda et al., "CORONARY THROMBOSIS THROMBOLYSIS IN PIGS - EFFECTS OF HEPARIN, ASA, AND THE THROMBIN INHIBITOR INOGATRAN/", Journal of pharmacological and toxicological methods, 39(2), 1998, pp. 81-89
45. HELFT G; BARA L; BLOCH MF; SAMAMA MM
    COMPARATIVE TIME-COURSE OF THROMBOLYSIS INDUCED BY INTRAVENOUS BOLUSES AND INFUSION OF STAPHYLOKINASE AND TISSUE-PLASMINOGEN ACTIVATOR IN ARABBIT ARTERIAL THROMBOSIS MODEL
    Blood coagulation & fibrinolysis
    
    G. Helft et al., "COMPARATIVE TIME-COURSE OF THROMBOLYSIS INDUCED BY INTRAVENOUS BOLUSES AND INFUSION OF STAPHYLOKINASE AND TISSUE-PLASMINOGEN ACTIVATOR IN ARABBIT ARTERIAL THROMBOSIS MODEL", Blood coagulation & fibrinolysis, 9(5), 1998, pp. 411-417
46. BAR FW; MEYER J; BOLAND J; BETRIU A; ARTMEYER B; CHARBONNIER B; MICHELS HR; TEBBE U; SPIECKER M; VERMEER F; VONFISENNE MJM; HOPKINS GR; BARTH H
    BOLUS ADMINISTRATION OF SARUPLASE IN EUROPE (BASE), A PILOT-STUDY IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    Journal of thrombosis and thrombolysis
    
    F.W. Bar et al., "BOLUS ADMINISTRATION OF SARUPLASE IN EUROPE (BASE), A PILOT-STUDY IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION", Journal of thrombosis and thrombolysis, 6(2), 1998, pp. 147-153
47. JANG IK; GIUGLIANO RP; MASSEY TJ; SCHWARZ RP
    A RANDOMIZED, BLINDED STUDY OF 2 DOSES OF NOVASTAN(R) (BRAND OF ARGATROBAN) VERSUS HEPARIN AS ADJUNCTIVE THERAPY TO RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR (ACCELERATED ADMINISTRATION) IN ACUTE MYOCARDIAL-INFARCTION - RATIONALE AND DESIGN OF THE MYOCARDIAL-INFARCTION USING NOVASTAN(R) AND T-PA (MINT) STUDY
    Journal of thrombosis and thrombolysis
    
    I.K. Jang et al., "A RANDOMIZED, BLINDED STUDY OF 2 DOSES OF NOVASTAN(R) (BRAND OF ARGATROBAN) VERSUS HEPARIN AS ADJUNCTIVE THERAPY TO RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR (ACCELERATED ADMINISTRATION) IN ACUTE MYOCARDIAL-INFARCTION - RATIONALE AND DESIGN OF THE MYOCARDIAL-INFARCTION USING NOVASTAN(R) AND T-PA (MINT) STUDY", Journal of thrombosis and thrombolysis, 5(1), 1998, pp. 49-52
48. SALVIONI A; PEREGO GB; MARENZI G; GALLI S; ASSANELLI E; GUAZZI MD
    PLATELET ACTIVITY IN THE EARLY-STAGE OF ACUTE MYOCARDIAL-INFARCTION -RELATION TO TIME OF PRESENTATION, TREATMENT WITH EITHER TISSUE-PLASMINOGEN ACTIVATOR OR STREPTOKINASE AND CYCLOOXYGENASE INHIBITION
    Journal of thrombosis and thrombolysis
    
    A. Salvioni et al., "PLATELET ACTIVITY IN THE EARLY-STAGE OF ACUTE MYOCARDIAL-INFARCTION -RELATION TO TIME OF PRESENTATION, TREATMENT WITH EITHER TISSUE-PLASMINOGEN ACTIVATOR OR STREPTOKINASE AND CYCLOOXYGENASE INHIBITION", Journal of thrombosis and thrombolysis, 5(1), 1998, pp. 65-71
49. DZAVIK V; CARERE RG; TEO KK; KNUDTSON ML; MARQUIS JF; BULLER CE
    AN OPEN DESIGN, MULTICENTER, RANDOMIZED TRIAL OF PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY VERSUS STENTING, WITH A HEPARIN-COATED STENT, OF TOTALLY OCCLUDED CORONARY-ARTERIES - RATIONALE, TRIAL DESIGN ANDBASE-LINE PATIENT CHARACTERISTICS
    Canadian journal of cardiology
    
    V. Dzavik et al., "AN OPEN DESIGN, MULTICENTER, RANDOMIZED TRIAL OF PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY VERSUS STENTING, WITH A HEPARIN-COATED STENT, OF TOTALLY OCCLUDED CORONARY-ARTERIES - RATIONALE, TRIAL DESIGN ANDBASE-LINE PATIENT CHARACTERISTICS", Canadian journal of cardiology, 14(6), 1998, pp. 825-832
50. GURBEL PA; SEREBRUANY VL; SHUSTOV AR; BAHR RD; CARPO C; OHMAN EA; TOPOL EJ
    EFFECTS OF RETEPLASE AND ALTEPLASE ON PLATELET-AGGREGATION AND MAJOR RECEPTOR EXPRESSION DURING THE FIRST 24 HOURS OF ACUTE MYOCARDIAL-INFARCTION TREATMENT
    Journal of the American College of Cardiology
    
    P.A. Gurbel et al., "EFFECTS OF RETEPLASE AND ALTEPLASE ON PLATELET-AGGREGATION AND MAJOR RECEPTOR EXPRESSION DURING THE FIRST 24 HOURS OF ACUTE MYOCARDIAL-INFARCTION TREATMENT", Journal of the American College of Cardiology, 31(7), 1998, pp. 1466-1473
51. LI A; WUN TC
    PROTEOLYSIS OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) BY PLASMIN - EFFECT ON TFPI ACTIVITY
    Thrombosis and haemostasis
    
    A. Li e T.C. Wun, "PROTEOLYSIS OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) BY PLASMIN - EFFECT ON TFPI ACTIVITY", Thrombosis and haemostasis, 80(3), 1998, pp. 423-427
52. DESCHENES I; FINKLE CD; WINOCOUR PD
    EFFECTIVE USE OF BCH-2763, A NEW POTENT INJECTABLE DIRECT THROMBIN INHIBITOR, IN COMBINATION WITH TISSUE-PLASMINOGEN ACTIVATOR (TPA) IN A RAT ARTERIAL THROMBOLYSIS MODEL
    Thrombosis and haemostasis
    
    I. Deschenes et al., "EFFECTIVE USE OF BCH-2763, A NEW POTENT INJECTABLE DIRECT THROMBIN INHIBITOR, IN COMBINATION WITH TISSUE-PLASMINOGEN ACTIVATOR (TPA) IN A RAT ARTERIAL THROMBOLYSIS MODEL", Thrombosis and haemostasis, 80(1), 1998, pp. 186-191
53. KAWASAKI T; SATO K; HIRAYAMA F; KOSHIO H; TANIUCHI Y; MATSUMOTO Y
    EFFECT OF A SYNTHETIC FACTOR XA INHIBITOR, YM-60828, ON BLOOD-VESSEL PATENCY IN COMBINATION WITH A THROMBOLYTIC AGENT AND ON BLOOD-LOSS FROM THE OPERATION SITE IN A RAT MODEL OF ARTERIAL THROMBOSIS
    Thrombosis and haemostasis
    
    T. Kawasaki et al., "EFFECT OF A SYNTHETIC FACTOR XA INHIBITOR, YM-60828, ON BLOOD-VESSEL PATENCY IN COMBINATION WITH A THROMBOLYTIC AGENT AND ON BLOOD-LOSS FROM THE OPERATION SITE IN A RAT MODEL OF ARTERIAL THROMBOSIS", Thrombosis and haemostasis, 79(4), 1998, pp. 859-864
54. Chicaud, P; Rademakers, JR; Millet, J
    The beneficial effect of a beta-D-xyloside, iliparcil, in the prevention of postthrombolytic rethrombosis in the rat
    HAEMOSTASIS
    
    P. Chicaud et al., "The beneficial effect of a beta-D-xyloside, iliparcil, in the prevention of postthrombolytic rethrombosis in the rat", HAEMOSTASIS, 28(6), 1998, pp. 313-320
55. STRECKER EPK; GOTTMANN D; BOOS IBL; VETTER S
    LOW-MOLECULAR-WEIGHT HEPARIN (REVIPARIN) REDUCES THE INCIDENCE OF FEMOROPOPLITEAL IN-STENT STENOSIS - PRELIMINARY-RESULTS OF AN ONGOING STUDY
    Cardiovascular and interventional radiology
    
    E.P.K. Strecker et al., "LOW-MOLECULAR-WEIGHT HEPARIN (REVIPARIN) REDUCES THE INCIDENCE OF FEMOROPOPLITEAL IN-STENT STENOSIS - PRELIMINARY-RESULTS OF AN ONGOING STUDY", Cardiovascular and interventional radiology, 21(5), 1998, pp. 375-379
56. DAVIES CH; ORMEROD OJM
    FAILED CORONARY THROMBOLYSIS
    Lancet
    
    C.H. Davies e O.J.M. Ormerod, "FAILED CORONARY THROMBOLYSIS", Lancet, 351(9110), 1998, pp. 1191-1196
57. YAMASHITA T; TSUDA Y; KONISHI Y; OKADA Y; MATSUOKA A; GIDDINGS JC; YAMAMOTO J
    THE ANTITHROMBOTIC EFFECT OF POTENT BIFUNCTIONAL THROMBIN INHIBITORS BASED ON HIRUDIN SEQUENCE, P551 AND P532, ON HE-NE LASER-INDUCED THROMBOSIS IN RAT MESENTERIC MICROVESSELS
    Thrombosis research
    
    T. Yamashita et al., "THE ANTITHROMBOTIC EFFECT OF POTENT BIFUNCTIONAL THROMBIN INHIBITORS BASED ON HIRUDIN SEQUENCE, P551 AND P532, ON HE-NE LASER-INDUCED THROMBOSIS IN RAT MESENTERIC MICROVESSELS", Thrombosis research, 90(5), 1998, pp. 199-206
58. OGATA N; OGAWA H; OGATA Y; NUMATA Y; MORIGAMI Y; SUEFUJI H; SOEJIMA H; SAKAMOTO T; YASUE H
    COMPARISON OF THROMBOLYTIC THERAPIES WITH MUTANT TPA (LANOTEPLASE SUN9216) AND RECOMBINANT TPA (ALTEPLASE) FOR ACUTE MYOCARDIAL-INFARCTION/
    Japanese Circulation Journal
    
    N. Ogata et al., "COMPARISON OF THROMBOLYTIC THERAPIES WITH MUTANT TPA (LANOTEPLASE SUN9216) AND RECOMBINANT TPA (ALTEPLASE) FOR ACUTE MYOCARDIAL-INFARCTION/", Japanese Circulation Journal, 62(11), 1998, pp. 801-806
59. MURPHY NP; PRATICO D; FITZGERALD DJ
    FUNCTIONAL RELEVANCE OF THE EXPRESSION OF LIGAND-INDUCED BINDING-SITES IN THE RESPONSE TO PLATELET GP LLB LLLA ANTAGONISTS IN-VIVO/
    The Journal of pharmacology and experimental therapeutics
    
    N.P. Murphy et al., "FUNCTIONAL RELEVANCE OF THE EXPRESSION OF LIGAND-INDUCED BINDING-SITES IN THE RESPONSE TO PLATELET GP LLB LLLA ANTAGONISTS IN-VIVO/", The Journal of pharmacology and experimental therapeutics, 286(2), 1998, pp. 945-951
60. ZUCKER TP; BONISCH D; MUCK S; WEBER AA; BRETSCHNEIDER E; GLUSA E; SCHROR K
    THROMBIN-INDUCED MITOGENESIS IN CORONARY-ARTERY SMOOTH-MUSCLE CELLS IS POTENTIATED BY THROMBOXANE A(2) AND INVOLVES UP-REGULATION OF THROMBOXANE RECEPTOR MESSENGER-RNA
    Circulation
    
    T.P. Zucker et al., "THROMBIN-INDUCED MITOGENESIS IN CORONARY-ARTERY SMOOTH-MUSCLE CELLS IS POTENTIATED BY THROMBOXANE A(2) AND INVOLVES UP-REGULATION OF THROMBOXANE RECEPTOR MESSENGER-RNA", Circulation, 97(6), 1998, pp. 589-595
61. SMALLING RW; ANDERSON HV
    PATHOPHYSIOLOGICAL INSIGHT INTO THE POSSIBLE OPTIMAL THERAPIES FOR ACUTE MYOCARDIAL-INFARCTION AND UNSTABLE ANGINA
    Circulation
    
    R.W. Smalling e H.V. Anderson, "PATHOPHYSIOLOGICAL INSIGHT INTO THE POSSIBLE OPTIMAL THERAPIES FOR ACUTE MYOCARDIAL-INFARCTION AND UNSTABLE ANGINA", Circulation, 97(1), 1998, pp. 10-11
62. VANBELLE E; LABLANCHE JM; BAUTERS C; RENAUD N; MCFADDEN EP; BERTRAND ME
    CORONARY ANGIOSCOPIC FINDINGS IN THE INFARCT-RELATED VESSEL WITHIN 1 MONTH OF ACUTE MYOCARDIAL-INFARCTION - NATURAL-HISTORY AND THE EFFECT OF THROMBOLYSIS
    Circulation
    
    E. Vanbelle et al., "CORONARY ANGIOSCOPIC FINDINGS IN THE INFARCT-RELATED VESSEL WITHIN 1 MONTH OF ACUTE MYOCARDIAL-INFARCTION - NATURAL-HISTORY AND THE EFFECT OF THROMBOLYSIS", Circulation, 97(1), 1998, pp. 26-33
63. Horie, H; Takahashi, M; Minai, K; Izumi, M; Takaoka, A; Nozawa, M; Yokohama, H; Fujita, T; Sakamoto, T; Kito, O; Okamura, H; Kinoshita, M
    Long-term beneficial effect of late reperfusion for acute anterior myocardial infarction with percutaneous transluminal coronary angioplasty
    CIRCULATION
    
    H. Horie et al., "Long-term beneficial effect of late reperfusion for acute anterior myocardial infarction with percutaneous transluminal coronary angioplasty", CIRCULATION, 98(22), 1998, pp. 2377-2382
64. BERRY CN; LUNVEN C; LECHAIRE I; GIRARDOT C; OCONNOR SE
    ANTITHROMBOTIC ACTIVITY OF A MONOCLONAL-ANTIBODY INDUCING THE SUBSTRATE FORM OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN RAT MODELS OF VENOUS AND ARTERIAL THROMBOSIS
    British Journal of Pharmacology
    
    C.N. Berry et al., "ANTITHROMBOTIC ACTIVITY OF A MONOCLONAL-ANTIBODY INDUCING THE SUBSTRATE FORM OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN RAT MODELS OF VENOUS AND ARTERIAL THROMBOSIS", British Journal of Pharmacology, 125(1), 1998, pp. 29-34
65. FRENCH JK; ELLIS CJ; WEBBER BJ; WILLIAMS BF; AMOS DJ; RAMANATHAN K; WHITLOCK RML; WHITE HD
    ABNORMAL CORONARY FLOW IN INFARCT ARTERIES 1 YEAR AFTER MYOCARDIAL-INFARCTION IS PREDICTED AT 4 WEEKS BY CORRECTED THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) FRAME COUNT AND STENOSIS SEVERITY
    The American journal of cardiology
    
    J.K. French et al., "ABNORMAL CORONARY FLOW IN INFARCT ARTERIES 1 YEAR AFTER MYOCARDIAL-INFARCTION IS PREDICTED AT 4 WEEKS BY CORRECTED THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) FRAME COUNT AND STENOSIS SEVERITY", The American journal of cardiology, 81(6), 1998, pp. 665-671
66. BRIEGER DB; MAK KH; WHITE HD; KLEIMAN NS; MILLER DP; VAHANIAN A; ROSS AM; CALIFF RM; TOPOL EJ
    BENEFIT OF EARLY SUSTAINED REPERFUSION IN PATIENTS WITH PRIOR MYOCARDIAL-INFARCTION (THE GUSTO-I TRIAL)
    The American journal of cardiology
    
    D.B. Brieger et al., "BENEFIT OF EARLY SUSTAINED REPERFUSION IN PATIENTS WITH PRIOR MYOCARDIAL-INFARCTION (THE GUSTO-I TRIAL)", The American journal of cardiology, 81(3), 1998, pp. 282-287
67. TAN WA; MOLITERNO DJ
    TIMI FLOW AND SURROGATE END-POINTS - WHAT YOU SEE IS NOT ALWAYS WHAT YOU GET
    The American heart journal
    
    W.A. Tan e D.J. Moliterno, "TIMI FLOW AND SURROGATE END-POINTS - WHAT YOU SEE IS NOT ALWAYS WHAT YOU GET", The American heart journal, 136(4), 1998, pp. 570-573
68. VANTHOF AWJ; DEBOER MJ; SURYAPRANATA H; HOORNTJE JCA; ZIJLSTRA F
    INCIDENCE AND PREDICTORS OF RESTENOSIS AFTER SUCCESSFUL PRIMARY CORONARY ANGIOPLASTY FOR ACUTE MYOCARDIAL-INFARCTION - THE IMPORTANCE OF AGE AND PROCEDURAL RESULT
    The American heart journal
    
    A.W.J. Vanthof et al., "INCIDENCE AND PREDICTORS OF RESTENOSIS AFTER SUCCESSFUL PRIMARY CORONARY ANGIOPLASTY FOR ACUTE MYOCARDIAL-INFARCTION - THE IMPORTANCE OF AGE AND PROCEDURAL RESULT", The American heart journal, 136(3), 1998, pp. 518-527
69. KAWANO K; AOKI I; AOKI N; HOMORI M; MAKI A; HIOKI Y; HASUMURA Y; TERANO A; ARAI T; MIZUNO H; ISHIKAWA K
    HUMAN PLATELET ACTIVATION BY THROMBOLYTIC AGENTS - EFFECTS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND UROKINASE ON PLATELET SURFACE P-SELECTIN EXPRESSION
    The American heart journal
    
    K. Kawano et al., "HUMAN PLATELET ACTIVATION BY THROMBOLYTIC AGENTS - EFFECTS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND UROKINASE ON PLATELET SURFACE P-SELECTIN EXPRESSION", The American heart journal, 135(2), 1998, pp. 268-271
70. MATTSSON C; BJORKMAN JA; ULVINGE JC
    MELAGATRAN, AND HIRUDIN AND HEPARIN AS ADJUNCTS TO TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN A CANINE MODEL OF CORONARY-ARTERY THROMBOLYSIS
    Fibrinolysis & proteolysis
    
    C. Mattsson et al., "MELAGATRAN, AND HIRUDIN AND HEPARIN AS ADJUNCTS TO TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN A CANINE MODEL OF CORONARY-ARTERY THROMBOLYSIS", Fibrinolysis & proteolysis, 11(3), 1997, pp. 121-128
71. COMMERFORD PJ
    HEPARIN AFTER ACUTE MYOCARDIAL-INFARCTION
    Cardiovascular drugs and therapy
    
    P.J. Commerford, "HEPARIN AFTER ACUTE MYOCARDIAL-INFARCTION", Cardiovascular drugs and therapy, 11(2), 1997, pp. 101-109
72. WILLIAMS MJA; MORISON IM; PARKER JH; STEWART RAH
    PROGRESSION OF THE CULPRIT LESION IN UNSTABLE CORONARY-ARTERY DISEASEWITH WARFARIN AND ASPIRIN VERSUS ASPIRIN ALONE - PRELIMINARY-STUDY
    Journal of the American College of Cardiology
    
    M.J.A. Williams et al., "PROGRESSION OF THE CULPRIT LESION IN UNSTABLE CORONARY-ARTERY DISEASEWITH WARFARIN AND ASPIRIN VERSUS ASPIRIN ALONE - PRELIMINARY-STUDY", Journal of the American College of Cardiology, 30(2), 1997, pp. 364-369
73. ZIJLSTRA F; BEUKEMA WP; VANTHOF AWJ; LIEM A; REIFFERS S; HOORNTJE JCA; SURYAPRANATA H; DEBOER MJ
    RANDOMIZED COMPARISON OF PRIMARY CORONARY ANGIOPLASTY WITH THROMBOLYTIC THERAPY IN LOW-RISK PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    Journal of the American College of Cardiology
    
    F. Zijlstra et al., "RANDOMIZED COMPARISON OF PRIMARY CORONARY ANGIOPLASTY WITH THROMBOLYTIC THERAPY IN LOW-RISK PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION", Journal of the American College of Cardiology, 29(5), 1997, pp. 908-912
74. LEADLEY RJ; KASIEWSKI CJ; BOSTWICK JS; BENTLEY R; MCVEY MJ; WHITE FJ; PERRONE MH; DUNWIDDIE CT
    COMPARISON OF ENOXAPARIN, HIRULOG, AND HEPARIN AS ADJUNCTIVE ANTITHROMBOTIC THERAPY DURING THROMBOLYSIS WITH RTPA IN THE STENOSED CANINE CORONARY-ARTERY
    Thrombosis and haemostasis
    
    R.J. Leadley et al., "COMPARISON OF ENOXAPARIN, HIRULOG, AND HEPARIN AS ADJUNCTIVE ANTITHROMBOTIC THERAPY DURING THROMBOLYSIS WITH RTPA IN THE STENOSED CANINE CORONARY-ARTERY", Thrombosis and haemostasis, 78(4), 1997, pp. 1278-1285
75. ALCIBAR J; GOCHI R; ONATE A; BARRENETXEA JI; RUMOROSO JR; SALAZAR H; JIMENEZ A; RODRIGO D; GONZALEZLIEBANA J; PENA N; CEMBELLIN JC
    LATE REOPENING OF A PATENT DUCTUS-ARTERIO SUS AFTER COMPLETE CLOSURE WITH THE RASHKINDS PROSTHESIS - SUSPECT OF A TRAUMATIC ORIGIN
    Revista espanola de cardiologia
    
    J. Alcibar et al., "LATE REOPENING OF A PATENT DUCTUS-ARTERIO SUS AFTER COMPLETE CLOSURE WITH THE RASHKINDS PROSTHESIS - SUSPECT OF A TRAUMATIC ORIGIN", Revista espanola de cardiologia, 50(2), 1997, pp. 133-136
76. LABHASETWAR V; SONG CX; LEVY RJ
    NANOPARTICLE DRUG-DELIVERY SYSTEM FOR RESTENOSIS
    Advanced drug delivery reviews
    
    V. Labhasetwar et al., "NANOPARTICLE DRUG-DELIVERY SYSTEM FOR RESTENOSIS", Advanced drug delivery reviews, 24(1), 1997, pp. 63-85
77. BECKER RC
    DYNAMICS OF CORONARY THROMBOLYSIS AND REOCCLUSION
    Clinical cardiology
    
    R.C. Becker, "DYNAMICS OF CORONARY THROMBOLYSIS AND REOCCLUSION", Clinical cardiology, 20(11), 1997, pp. 2-5
78. REBELLO SS; MILLER BV; BASLER GC; LUCCHESI BR
    CVS-1123, A DIRECT THROMBIN INHIBITOR, PREVENTS OCCLUSIVE ARTERIAL AND VENOUS THROMBOSIS IN A CANINE MODEL OF VASCULAR INJURY
    Journal of cardiovascular pharmacology
    
    S.S. Rebello et al., "CVS-1123, A DIRECT THROMBIN INHIBITOR, PREVENTS OCCLUSIVE ARTERIAL AND VENOUS THROMBOSIS IN A CANINE MODEL OF VASCULAR INJURY", Journal of cardiovascular pharmacology, 29(2), 1997, pp. 240-249
79. SANCHEZ EF; BUSH LR; SWENSON S; MARKLAND FS
    CHIMERIC FIBROLASE - COVALENT ATTACHMENT OF AN RGD-LIKE PEPTIDE TO CREATE A POTENTIALLY MORE EFFECTIVE THROMBOLYTIC AGENT
    Thrombosis research
    
    E.F. Sanchez et al., "CHIMERIC FIBROLASE - COVALENT ATTACHMENT OF AN RGD-LIKE PEPTIDE TO CREATE A POTENTIALLY MORE EFFECTIVE THROMBOLYTIC AGENT", Thrombosis research, 87(3), 1997, pp. 289-302
80. YANG LH; FAREED J
    VASOMODULATORY ACTION OF CLOPIDOGREL AND TICLOPIDINE
    Thrombosis research
    
    L.H. Yang e J. Fareed, "VASOMODULATORY ACTION OF CLOPIDOGREL AND TICLOPIDINE", Thrombosis research, 86(6), 1997, pp. 479-491
81. YAMASHITA T; TSUJI T; MATSUOKA A; GIDDINGS JC; YAMAMOTO J
    THE ANTITHROMBOTIC EFFECT OF SYNTHETIC LOW-MOLECULAR-WEIGHT HUMAN FACTOR XA INHIBITOR DX-9065A, ON HE-NE LASER-INDUCED THROMBOSIS IN RAT MESENTERIC MICROVESSELS
    Thrombosis research
    
    T. Yamashita et al., "THE ANTITHROMBOTIC EFFECT OF SYNTHETIC LOW-MOLECULAR-WEIGHT HUMAN FACTOR XA INHIBITOR DX-9065A, ON HE-NE LASER-INDUCED THROMBOSIS IN RAT MESENTERIC MICROVESSELS", Thrombosis research, 85(1), 1997, pp. 45-51
82. REBELLO SS; DRISCOLL EM; LUCCHESI BR
    TP-9201, A GLYCOPROTEIN IIB IIIA PLATELET RECEPTOR ANTAGONIST, PREVENTS RETHROMBOSIS AFTER SUCCESSFUL ARTERIAL THROMBOLYSIS IN THE DOG/
    Stroke
    
    S.S. Rebello et al., "TP-9201, A GLYCOPROTEIN IIB IIIA PLATELET RECEPTOR ANTAGONIST, PREVENTS RETHROMBOSIS AFTER SUCCESSFUL ARTERIAL THROMBOLYSIS IN THE DOG/", Stroke, 28(9), 1997, pp. 1789-1796
83. MOUSA SA; MU DX; LUCCHESI BR
    PREVENTION OF CAROTID-ARTERY THROMBOSIS BY ORAL PLATELET GPIIB IIIA ANTAGONIST IN DOGS/
    Stroke
    
    S.A. Mousa et al., "PREVENTION OF CAROTID-ARTERY THROMBOSIS BY ORAL PLATELET GPIIB IIIA ANTAGONIST IN DOGS/", Stroke, 28(4), 1997, pp. 830-835
84. PRATICO D; MURPHY NP; FITZGERALD DJ
    INTERACTION OF A THROMBIN INHIBITOR AND A PLATELET GP IIB IIIA ANTAGONIST IN-VIVO - EVIDENCE THAT THROMBIN MEDIATES PLATELET-AGGREGATION AND SUBSEQUENT THROMBOXANE A(2) FORMATION DURING CORONARY THROMBOLYSIS/
    The Journal of pharmacology and experimental therapeutics
    
    D. Pratico et al., "INTERACTION OF A THROMBIN INHIBITOR AND A PLATELET GP IIB IIIA ANTAGONIST IN-VIVO - EVIDENCE THAT THROMBIN MEDIATES PLATELET-AGGREGATION AND SUBSEQUENT THROMBOXANE A(2) FORMATION DURING CORONARY THROMBOLYSIS/", The Journal of pharmacology and experimental therapeutics, 281(3), 1997, pp. 1178-1185
85. BIRNBAUM Y; HALE SL; KLONER RA
    CHANGES IN R-WAVE AMPLITUDE - ECG-DIFFERENTIATION BETWEEN EPISODES OFREOCCLUSION AND REPERFUSION ASSOCIATED WITH ST-SEGMENT ELEVATION
    Journal of electrocardiology
    
    Y. Birnbaum et al., "CHANGES IN R-WAVE AMPLITUDE - ECG-DIFFERENTIATION BETWEEN EPISODES OFREOCCLUSION AND REPERFUSION ASSOCIATED WITH ST-SEGMENT ELEVATION", Journal of electrocardiology, 30(3), 1997, pp. 211-216
86. FRIEDERICH PW; LEVI M; BIEMOND BJ; CHARLTON P; TEMPLETON D; VANZONNEVELD AJ; BEVAN P; PANNEKOEK H; TENCATE JW
    NOVEL LOW-MOLECULAR-WEIGHT INHIBITOR OF PAI-1 (XR5118) PROMOTES ENDOGENOUS FIBRINOLYSIS AND REDUCES POSTTHROMBOLYSIS THROMBUS GROWTH IN RABBITS
    Circulation
    
    P.W. Friederich et al., "NOVEL LOW-MOLECULAR-WEIGHT INHIBITOR OF PAI-1 (XR5118) PROMOTES ENDOGENOUS FIBRINOLYSIS AND REDUCES POSTTHROMBOLYSIS THROMBUS GROWTH IN RABBITS", Circulation, 96(3), 1997, pp. 916-921
87. BODE C; HANSON SR; SCHMEDTJE JF; HABER E; MEHWALD P; KELLY AB; HARKER LA; RUNGE MS
    ANTITHROMBOTIC POTENCY OF HIRUDIN IS INCREASED IN NONHUMAN-PRIMATES BY FIBRIN TARGETING
    Circulation
    
    C. Bode et al., "ANTITHROMBOTIC POTENCY OF HIRUDIN IS INCREASED IN NONHUMAN-PRIMATES BY FIBRIN TARGETING", Circulation, 95(4), 1997, pp. 800-804
88. OHMAN EM; KLEIMAN NS; GACIOCH G; WORLEY SJ; NAVETTA FI; TALLEY JD; ANDERSON HV; ELLIS SG; COHEN MD; SPRIGGS D; MILLER M; KEREIAKES D; YAKUBOV S; KITT MM; SIGMON KN; CALIFF RM; KRUCOFF MW; TOPOL EJ
    COMBINED ACCELERATED TISSUE-PLASMINOGEN ACTIVATOR AND PLATELET GLYCOPROTEIN IIB IIIA INTEGRIN RECEPTOR BLOCKADE WITH INTEGRIN IN ACUTE MYOCARDIAL-INFARCTION - RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED, DOSE-RANGING TRIAL/
    Circulation
    
    E.M. Ohman et al., "COMBINED ACCELERATED TISSUE-PLASMINOGEN ACTIVATOR AND PLATELET GLYCOPROTEIN IIB IIIA INTEGRIN RECEPTOR BLOCKADE WITH INTEGRIN IN ACUTE MYOCARDIAL-INFARCTION - RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED, DOSE-RANGING TRIAL/", Circulation, 95(4), 1997, pp. 846-854
89. VANTHOF AW; ZIJLSTRA F; DEBOER MJ; LIEM AL; HOORNTJE JC; SURYAPRANATA H
    PATENCY AND REINFARCTION IN LATE-ENTRY MYOCARDIAL INFARCT PATIENTS TREATED WITH REPERFUSION THERAPY
    Angiology
    
    A.W. Vanthof et al., "PATENCY AND REINFARCTION IN LATE-ENTRY MYOCARDIAL INFARCT PATIENTS TREATED WITH REPERFUSION THERAPY", Angiology, 48(3), 1997, pp. 215-222
90. WARD SR; SUTTON JM; PIEPER KS; SCHWAIGER M; CALIFF RM; TOPOL EJ
    EFFECTS OF THROMBOLYTIC REGIMEN, EARLY CATHETERIZATION, AND PREDISCHARGE ANGIOGRAPHIC VARIABLES ON 6-WEEK LEFT-VENTRICULAR FUNCTION
    The American journal of cardiology
    
    S.R. Ward et al., "EFFECTS OF THROMBOLYTIC REGIMEN, EARLY CATHETERIZATION, AND PREDISCHARGE ANGIOGRAPHIC VARIABLES ON 6-WEEK LEFT-VENTRICULAR FUNCTION", The American journal of cardiology, 79(5), 1997, pp. 539-544
91. DREW BJ; ADAMS MG; PELTER MM; WUNG SF; CALDWELL MA
    COMPARISON OF STANDARD AND DERIVED 12-LEAD ELECTROCARDIOGRAMS FOR DIAGNOSIS OF CORONARY ANGIOPLASTY-INDUCED MYOCARDIAL-ISCHEMIA
    The American journal of cardiology
    
    B.J. Drew et al., "COMPARISON OF STANDARD AND DERIVED 12-LEAD ELECTROCARDIOGRAMS FOR DIAGNOSIS OF CORONARY ANGIOPLASTY-INDUCED MYOCARDIAL-ISCHEMIA", The American journal of cardiology, 79(5), 1997, pp. 639-644
92. KURISU S; SATO H; TATEISHI H; KAWAGOE T; ISHIHARA M; SHIMATANI Y; SAKAI K; UEDA K; MATSUURA H
    DIRECTIONAL CORONARY ATHERECTOMY FOR THE TREATMENT OF ACUTE MYOCARDIAL-INFARCTION
    The American heart journal
    
    S. Kurisu et al., "DIRECTIONAL CORONARY ATHERECTOMY FOR THE TREATMENT OF ACUTE MYOCARDIAL-INFARCTION", The American heart journal, 134(3), 1997, pp. 345-350
93. FATHORDOUBADI F; HUEHNS TY; ALMOHAMMAD A; BEATT KJ
    SIGNIFICANCE OF THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION SCORING SYSTEM IN ASSESSING INFARCT-RELATED ARTERY REPERFUSION AND MORTALITY-RATES AFTER ACUTE MYOCARDIAL-INFARCTION
    The American heart journal
    
    F. Fathordoubadi et al., "SIGNIFICANCE OF THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION SCORING SYSTEM IN ASSESSING INFARCT-RELATED ARTERY REPERFUSION AND MORTALITY-RATES AFTER ACUTE MYOCARDIAL-INFARCTION", The American heart journal, 134(1), 1997, pp. 62-68
94. EMMERICH K; KLOS M; ULBRICHT LJ; KRAKAU I; PROBST H
    TREATMENT OF MYOCARDIAL-INFARCTION BY PTCA WITHIN 12 TO 24 HOURS AFTER ONSET OF PAIN
    Deutsche Medizinische Wochenschrift
    
    K. Emmerich et al., "TREATMENT OF MYOCARDIAL-INFARCTION BY PTCA WITHIN 12 TO 24 HOURS AFTER ONSET OF PAIN", Deutsche Medizinische Wochenschrift, 122(40), 1997, pp. 1201-1206
95. SEREBRUANY VL; HERZOG WR; GURBEL PA
    SERIAL CHANGES OF NATURAL ANTITHROMBOTICS DURING MYOCARDIAL ISCHEMIA-REPERFUSION IN SWINE - EFFECTS OF MAGNESIUM, DILTIAZEM, AND A NOVEL MAC-1 INHIBITOR
    Blood coagulation & fibrinolysis
    
    V.L. Serebruany et al., "SERIAL CHANGES OF NATURAL ANTITHROMBOTICS DURING MYOCARDIAL ISCHEMIA-REPERFUSION IN SWINE - EFFECTS OF MAGNESIUM, DILTIAZEM, AND A NOVEL MAC-1 INHIBITOR", Blood coagulation & fibrinolysis, 7(6), 1996, pp. 632-640
96. YUSUF SW; SANDERSON H; HEPTINSTALL S; NURDEN AT; WENHAM PW; HOPKINSON BR
    ADP-INDUCED P-SELECTIN EXPRESSION ON PLATELETS AS A PREDICTOR OF SUCCESSFUL THROMBOLYSIS
    Blood coagulation & fibrinolysis
    
    S.W. Yusuf et al., "ADP-INDUCED P-SELECTIN EXPRESSION ON PLATELETS AS A PREDICTOR OF SUCCESSFUL THROMBOLYSIS", Blood coagulation & fibrinolysis, 7(2), 1996, pp. 266-269
97. NICOLINI FA; LEE P; MALYCKY JL; LEFKOVITS J; KOTTKEMARCHANT K; PLOW EF; TOPOL EJ
    SELECTIVE-INHIBITION OF FACTOR XA DURING THROMBOLYTIC THERAPY MARKEDLY IMPROVES CORONARY-ARTERY PATENCY IN A CANINE MODEL OF CORONARY-THROMBOSIS
    Blood coagulation & fibrinolysis
    
    F.A. Nicolini et al., "SELECTIVE-INHIBITION OF FACTOR XA DURING THROMBOLYTIC THERAPY MARKEDLY IMPROVES CORONARY-ARTERY PATENCY IN A CANINE MODEL OF CORONARY-THROMBOSIS", Blood coagulation & fibrinolysis, 7(1), 1996, pp. 39-48
98. BLEICH SD
    ANGIOGRAPHIC STUDIES DEMONSTRATING THE NEED FOR CONJUNCTIVE ANTICOAGULATION
    Coronary artery disease
    
    S.D. Bleich, "ANGIOGRAPHIC STUDIES DEMONSTRATING THE NEED FOR CONJUNCTIVE ANTICOAGULATION", Coronary artery disease, 7(7), 1996, pp. 516-521
99. FITZGERALD D; MURPHY N
    ARGATROBAN - A SYNTHETIC THROMBIN INHIBITOR OF LOW RELATIVE MOLECULAR-MASS
    Coronary artery disease
    
    D. Fitzgerald e N. Murphy, "ARGATROBAN - A SYNTHETIC THROMBIN INHIBITOR OF LOW RELATIVE MOLECULAR-MASS", Coronary artery disease, 7(6), 1996, pp. 455-458
100. KORNOWSKI R; ELDOR A; WERBER MM; EZOV N; ZWANG E; NIMROD A; CHERNINE A; FINKELSTEIN A; PANET A; LANIADO S; KEREN G
     ENHANCEMENT OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR THROMBOLYSIS WITH A SELECTIVE FACTOR XA INHIBITOR DERIVED FROM THE LEECH HIRUDO-MEDICINALIS - COMPARISON WITH HEPARIN AND HIRUDIN IN A RABBIT THROMBOSIS MODEL
     Coronary artery disease
     
     R. Kornowski et al., "ENHANCEMENT OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR THROMBOLYSIS WITH A SELECTIVE FACTOR XA INHIBITOR DERIVED FROM THE LEECH HIRUDO-MEDICINALIS - COMPARISON WITH HEPARIN AND HIRUDIN IN A RABBIT THROMBOSIS MODEL", Coronary artery disease, 7(12), 1996, pp. 903-909